Cargando…

The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies

Artificial intelligence (AI) has the potential to revolutionize the drug discovery process, offering improved efficiency, accuracy, and speed. However, the successful application of AI is dependent on the availability of high-quality data, the addressing of ethical concerns, and the recognition of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco-González, Alexandre, Cabezón, Alfonso, Seco-González, Alejandro, Conde-Torres, Daniel, Antelo-Riveiro, Paula, Piñeiro, Ángel, Garcia-Fandino, Rebeca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302890/ https://www.ncbi.nlm.nih.gov/pubmed/37375838 http://dx.doi.org/10.3390/ph16060891

Ejemplares similares

The Lord of the NanoRings: Cyclodextrins and the battle against SARS-CoV-2
por: Garrido, Pablo F., et al.
Publicado: (2020)

Unravelling hierarchical levels of structure in lipid membranes
por: Blanco-González, Alexandre, et al.
Publicado: (2022)

AI in drug discovery: Applications, opportunities, and challenges
por: Bittner, Martin-Immanuel, et al.
Publicado: (2022)

Transmembrane Self-Assembled Cyclic Peptide Nanotubes Based on α‐Residues and Cyclic δ‐Amino Acids: A Computational Study
por: Blanco-González, Alexandre, et al.
Publicado: (2021)

Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides?
por: Garcia-Fandino, Rebeca, et al.
Publicado: (2021)

Molecular Dynamics Simulations of Transmembrane Cyclic Peptide Nanotubes Using Classical Force Fields, Hydrogen Mass Repartitioning, and Hydrogen Isotope Exchange Methods: A Critical Comparison
por: Conde, Daniel, et al.
Publicado: (2022)

An immersive journey to the molecular structure of SARS-CoV-2: Virtual reality in COVID-19
por: Calvelo, Martín, et al.
Publicado: (2020)

Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-β-cyclodextrins and remdesivir
por: Piñeiro, Ángel, et al.
Publicado: (2021)

Challenges and Opportunities in Deploying COVID-19 Cough AI Systems
por: Khanzada, Amil, et al.
Publicado: (2021)

Fairness and accountability of AI in disaster risk management: Opportunities and challenges
por: Gevaert, Caroline M., et al.
Publicado: (2021)

Rings, Hexagons, Petals, and Dipolar Moment Sink-Sources: The Fanciful Behavior of Water around Cyclodextrin Complexes
por: F. Garrido, Pablo, et al.
Publicado: (2020)

AI-assisted diplomatic decision-making during crises—Challenges and opportunities
por: Pokhriyal, Neeti, et al.
Publicado: (2023)

Opportunities in Open Science With AI
por: Wang, Kuansan
Publicado: (2019)

Metallodrugs are unique: opportunities and challenges of discovery and development
por: Anthony, Elizabeth J., et al.
Publicado: (2020)

Opportunities and Challenges of Data-Driven Virus Discovery
por: Lauber, Chris, et al.
Publicado: (2022)

An Update on CFTR Drug Discovery: Opportunities and Challenges
por: D’Ursi, Pasqualina, et al.
Publicado: (2022)

Deuterium in drug discovery: progress, opportunities and challenges
por: Di Martino, Rita Maria Concetta, et al.
Publicado: (2023)

The AI for Scientific Discovery Network(+)
por: Kanza, Samantha, et al.
Publicado: (2021)

The AI gambit: leveraging artificial intelligence to combat climate change—opportunities, challenges, and recommendations
por: Cowls, Josh, et al.
Publicado: (2021)

Variant‐level matching for diagnosis and discovery: Challenges and opportunities
por: Rodrigues, Eliete da S., et al.
Publicado: (2022)

Discovery of small molecule cancer drugs: Successes, challenges and opportunities
por: Hoelder, Swen, et al.
Publicado: (2012)

Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery
por: Waman, Vaishali P., et al.
Publicado: (2019)

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology
por: Shen, Xinpeng, et al.
Publicado: (2020)

Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
por: Meqbil, Yazan J., et al.
Publicado: (2022)

Graph-Driven Reaction Discovery: Progress, Challenges, and Future Opportunities
por: Ismail, Idil, et al.
Publicado: (2022)

Perspective on the challenges and opportunities of accelerating drug discovery with artificial intelligence
por: Santa Maria, John P., et al.
Publicado: (2023)

AI and surgery — Skynet or a great opportunity?
por: Harvey, Edward J., et al.
Publicado: (2023)

Emerging challenges in AI and the need for AI ethics education
por: Borenstein, Jason, et al.
Publicado: (2020)

Enhancing ADHD Medication Adherence: Challenges and Opportunities
por: Charach, Alice, et al.
Publicado: (2013)

New Opportunities, Challenges, and Applications of Edge-AI for Connected Healthcare in Internet of Medical Things for Smart Cities
por: Kamruzzaman, M. M., et al.
Publicado: (2022)

AI-Enabled Opportunities and Transformation Challenges for SMEs in the Post-pandemic Era: A Review and Research Agenda
por: Lu, Xiaoqian, et al.
Publicado: (2022)

AI-Driven Aeronautical Ad Hoc Networks for 6G Wireless: Challenges, Opportunities, and the Road Ahead
por: Bilen, Tuğçe, et al.
Publicado: (2022)

A systematic review of ethical challenges and opportunities of addressing domestic violence with AI-technologies and online tools
por: Novitzky, Peter, et al.
Publicado: (2023)

AI in drug discovery and its clinical relevance
por: Qureshi, Rizwan, et al.
Publicado: (2023)

Data mining and knowledge discovery for big data: methodologies, challenge and opportunities
por: Chu, Wesley
Publicado: (2014)

Drug discovery in ophthalmology: past success, present challenges, and future opportunities
por: Gower, Nicholas J. D., et al.
Publicado: (2016)

“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
por: Matthews, Holly, et al.
Publicado: (2016)

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
por: Biber, Knut, et al.
Publicado: (2019)

Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities
por: Pohl, Laura, et al.
Publicado: (2022)

Biometrics: Accessibility challenge or opportunity?
por: Blanco-Gonzalo, Ramon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nbnc8sg4p53gsa46ic21r9gtu0